AOD9604

Overview

AOD9604 (Advanced Obesity Drug 9604) is a synthetic peptide fragment derived from the C-terminus of human growth hormone (hGH). It is designed to selectively stimulate lipolysis (fat breakdown) without influencing growth or insulin-like effects. In laboratory settings, AOD9604 is studied for its ability to modulate fat metabolism pathways in preclinical models such as laboratory rodents.

Benefits

Recent preclinical studies suggest that AOD9604 may help promote the breakdown of stored fat and inhibit new fat formation, supporting research on obesity and metabolic disorders. Unlike full-length hGH, AOD9604 appears to act specifically on adipose tissue without affecting blood sugar regulation or lean muscle growth, making it valuable for targeted metabolic research.
Source: Ng FM, et al. Anti-obesity effects of AOD9604, a lipolytic fragment of human growth hormone, in diet-induced obese mice. Scientific Reports, 2022.

Possible Side Effects

In laboratory research, test subjects administered AOD9604 generally display minimal side effects. Mild injection site irritation or temporary digestive changes have occasionally been reported depending on dosage, study duration, and species.
Source: Ng FM, et al., Scientific Reports, 2022.

Dosage & Administration

AOD9604 is typically administered via subcutaneous injection under approved laboratory research protocols. Common research dosages range from 200 mcg to 500 mcg per injection, usually administered daily depending on study goals, test species, and experimental design.
For laboratory research use only. Not for human consumption.

Summary

AOD9604 is a synthetic peptide fragment of hGH developed exclusively for laboratory research focused on fat metabolism and obesity studies in preclinical models. Research suggests it may selectively promote fat breakdown without the broader growth effects of full-length growth hormone, with mild side effects such as injection site irritation occasionally observed in test subjects. AOD9604 is administered via subcutaneous injection, with dosage and frequency tailored to each study’s goals and species.
Strictly for research purposes only. Not for human use.